Locomotory patterns, spatiotemporal organization of exploration and spatial memory in serotonin transporter knockout mice

Brain Research

Volumn 1169, Issue 1, 2007, Pages 87-97

  Kalueff, Allan V ^a   Jensen, Catherine L ^a   Murphy, Dennis L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Elevated plus maze; Habituation; Meandering; Open field test; Patterns of locomotion; Serotonin transporter knockout mice; Spatiotemporal distribution

Indexed keywords

SEROTONIN TRANSPORTER;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; GENETIC MODEL; HABITUATION; HETEROZYGOTE; HOMOZYGOTE; KNOCKOUT MOUSE; LOCOMOTION; MALE; MAZE TEST; MOUSE; NEUROPSYCHIATRY; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; SPATIAL MEMORY; VIDEORECORDING; WILD TYPE;

ANIMALS; ANXIETY DISORDERS; AVOIDANCE LEARNING; BRAIN; BRAIN CHEMISTRY; DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MEMORY; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SPACE PERCEPTION; TIME FACTORS; TIME PERCEPTION;

MUS;

EID: 34548516132     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.07.009     Document Type: Article

References (81)

1. Adamec R., Burton P., Blundell J., Murphy D.L., and Holmes A. Vulnerability to mild predator stress in serotonin transporter knockout mice. Behav. Brain Res. 170 (2006) 126-140
2. Andreatini R.E., and Bacellar L.F. Animal models: trait or state measure? The test-retest reliability of the elevated plus-maze and behavioral despair. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 24 (2000) 549-560
3. Ansorge M.S., Zhou M., Lira A., and Gingrich J.A. Progressive motor deficits in mice lacking the serotonin transporter. Dev. Psychobiol. 3 (2003) 246
4. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner D., Heils A., Mossner R., Westphal H., and Lesch K.P. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("ecstasy") in serotonin transporter-deficient mice. Mol. Pharmacol. 53 (1998) 649-655
5. 3H]muscimol binding in the rat hippocampus. Eur. J. Pharmacol. 353 (1998) 5-12
6. Blakely R.D. Physiological genomics of antidepressant targets: keeping the periphery in mind. J. Neurosci. 21 (2001) 8319-8323
7. Bliziotes M., Gunness M., Eshleman A., and Wiren K. The role of dopamine and serotonin in regulating bone mass and strength: studies on dopamine and serotonin transporter null mice. J. Musculoskelet. Interact. 2 (2002) 291-295
8. Carobrez A.P., and Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci. Biobehav. Rev. 29 (2005) 1193-1205
9. Carroll J.C., Boyce-Rustay J.M., Millstein R., Yang R., Wiedholz L.M., Murphy D.L., and Holmes A. Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behav. Genet. 37 (2007) 214-222
10. Crawley J.N. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res. 835 (1999) 18-26
11. Crawley J.N. What's Wrong with My Mouse? Behavioural Phenotyping of Transgenic and Knockout Mice (2000), Wiley-Liss, NY
12. 4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J. Neurosci. 19 (1999) 9550-9556
13. Egashira N., Matsumoto Y., Mishima K., Iwasaki K., Fujioka M., Matsushita M., Shoyama Y., Nishimura R., and Fujiwara M. Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization. Pharmacol. Biochem. Behav. 83 (2006) 161-167
14. Eilam D. Locomotor activity in common spiny mice (Acomys cahirinuse): the effect of light and environmental complexity. BMC Ecol. 4 (2004) 16
15. Esaki T., Cook M., Shimoji K., Murphy D.L., Sokoloff L., and Holmes A. Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5582-5587
16. Finger E.C., Marsh A.A., Buzas B., Kamel N., Rhodes R., Vythilingham M., Pine D.S., Goldman D., and Blair J.R. The impact of tryptophan depletion and 5-HTTLPR genotype on passive avoidance and response reversal instrumental learning tasks. Neuropsychopharmacology 32 (2007) 206-215
17. Fonio E., Benjamini Y., Sakov A., and Golani I. Wild mouse open field behavior is embedded within the multidimensional data space spanned by laboratory inbred strains. Genes Brain Behav. 5 (2006) 380-388
18. Garner J.P. Stereotypies and other abnormal repetitive behaviors: potential impact on validity, reliability, and replicability of scientific outcomes. ILAR J. 46 (2005) 106-117
19. Geyer M.A., and Markou A. The role of preclinical models in the development of psychotropic drugs. In: Davis K.L., Charney D., and Coyle J.T. (Eds). Neuropsychopharmacology: The Fifth Generation of Progress (2002), Lippincott Williams and Wilkins, NY 445-455
20. Gingrich J.A., and Hen R. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology 155 (2001) 1-10
21. Goitz F. Serotonin syndrome. Utox Update 4 (2002) 1-4
22. Hasler G., Kazuba D., and Murphy D.L. Factor analysis of obsessive-compulsive disorder YBOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism. Am. J. Med. Genet. Neuropsychiatr. Genet. 141 (2006) 403-408
23. Hariri A.R. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn. Sci. 10 (2006) 182-191
24. Hill R.A., McInnes K.J., Gong E.C., Jones M.E., Simpson E.R., and Boon W.C. Estrogen deficient male mice develop compulsive behavior. Biol. Psychiatry 61 (2007) 359-366
25. Holmes A., and Hariri A.R. The serotonin transporter gene-linked polymorphism and negative emotionality: placing single gene effects in the context of genetic background and environment. Genes Brain Behav. 2 (2003) 325-332
26. Holmes A., Yang R.J., Murphy D.L., and Crawley J.N. Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27 (2002) 914-923
27. Holmes A., Murphy D.L., and Crawley J.N. Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology 161 (2002) 160-167
28. Holmes A., Li Q., Murphy D.L., Gold E., and Crawley J.N. Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav. 2 (2003) 365-380
29. Holmes A., Yang R.J., Lesch K.P., Crawley J.N., and Murphy D.L. Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 28 (2003) 2077-2088
30. Holmes A., Murphy D.L., and Crawley J.N. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol. Psychiatry 54 (2003) 953-959
31. Homberg J., Ellenbroek B., Olivier B., Ronken E., De Boer S., Schoffelmeer A., Pattij T., Vanderschuren L., de Vries T., and Cuppen E. Serotonin transporter knock-out rats display cocaine supersensitivity and reduced impulsivity. Soc. Neurosci. Abstr. 21 (2006) 5
32. Isbell L.A., Pruetz J.D., Nzuma B.M., and Young T.P. Comparing measures of travel distances in primates: methodological considerations and socioecological implications. Am. J. Primatol. 48 (1999) 87-98
33. Isbister G.K., and Buckley N.A. The pathophysiology of serotonin toxicity in animals and humans. Clin. Neuropharmacol. 28 (2005) 205-214
34. Izidio G.S., Spricigo L., and Ramos A. Genetic differences in the elevated plus-maze persist after first exposure of inbred rats to the test apparatus. Behav. Processes 68 (2005) 129-134
35. Kafkafi N., and Elmer G.I. Texture of locomotor path: a replicable characterization of a complex behavioral phenotype. Genes Brain Behav. 4 (2005) 431-443
36. Kafkafi N., and Elmer G.I. Activity density in the open field: a measure for differentiating the effect of psychostimulants. Pharmacol. Biochem. Behav. 80 (2005) 239-249
37. Kalueff A.V. Neurobiology of memory and anxiety: from genes to behavior. Neural Plasticity 2007 (2007) 1-12
38. Kalueff A.V., Keisala T., Minasyan A., Kuuslahti M., and Tuohimaa P. Temporal stability of novelty exploration in mice exposed to different open field tests. Behav. Processes 72 (2006) 104-112
39. Kalueff A.V., Gallagher P.S., and Murphy D.L. Are the serotonin transporter knockout mice "depressed"?: hypoactivity but no anhedonia. NeuroReport 17 (2006) 1347-1351
40. Kalueff A.V., Fox M.A., Gallagher P.S., and Murphy D.L. Hypolocomotion, anxiety and serotonin syndrome-like behavior contribute to the complex phenotype of serotonin transporter knockout mice. Genes Brain Behav. 6 (2007) 389-400
41. Kalueff A.V., Ren-Patterson R., and Murphy D.L. The developing utility of heterozygous (+/-) mouse models in monoamine brain research. Trends Pharmacol. Sci. 28 (2007) 122-127
42. Keitsaro N., Kaslin J., Anichtchik O.V., and Panula P. Modulation of the histaminergic system and behaviour by alpha-fluoromethylhistidine in zebrafish. J. Neurochem. 86 (2003) 432-441
43. Lapin I.P., Khaunina R.A., and Mirzaev S.M. Vertical motor activity of mice is slowed by lower doses of psychotropic drugs than horizontal. Bull. Eksp. Biol. Med. 120 (1995) 385-387
44. Lappanen P.K., Ravaja N., and Ewalds-Kvist S.B. Twenty-three generations of mice bidirectionally selected for open-field thigmotaxis: selection response and repeated exposure to the open field. Behav. Processes 72 (2006) 23-31
45. Lepicard E.M., Venault P., Abourachid A., Pelle E., Chapouthier G., and Gasc J.P. Spatio-temporal analysis of locomotion in BALB/cByJ and C57BL/6J mice in different environmental conditions. Behav. Brain Res. 167 (2006) 365-372
46. Lesch K.P. Genetic alterations of the murine serotonergic gene pathway: the neurodevelopmental basis of anxiety. Handb. Exp. Pharmacol. 169 (2005) 71-112
47. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Muller C.R., Hamer D.H., and Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 (1996) 1527-1531
48. Lesch K.P., Zeng Y., Reif A., and Gutknecht L. Anxiety-related traits in mice with modified genes of the serotonergic pathway. Eur. J. Pharmacol. 480 (2003) 185-204
49. Leussis M.P., and Bolivar V.J. Habituation in rodents: a review of behavior, neurobiology, and genetics. Neurosci. Biobehav. Rev. 30 (2006) 1045-1064
50. Li Q. Cellular and molecular alterations in mice with deficient and reduced serotonin transporters. Mol. Neurobiol. 34 (2006) 51-65
51. Lira A., Zhou M., Castanon N., Ansorge M.S., Gordon J.A., Francis J.H., Bradley-Moore M., Lira J., Underwood M.D., Arango V., Kung H.F., Hofer M.A., Hen R., and Gingrich J.A. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol. Psychiatry 54 (2003) 960-971
52. Mar A., Spreekmeester E., and Rochford J. Fluoxetine-induced increases in open-field habituation in the olfactory bulbectomized rat depend on test aversiveness but not on anxiety. Pharmacol. Biochem. Behav. 73 (2002) 703-712
53. Martin J.R. A portrait of locomotor behaviour in Drosophila determined by a video-tracking paradigm. Behav. Processes 67 (2004) 207-219
54. Murphy D.L., Li Q., Engel S., Wichems C., Andrews A., Lesch K.P., and Uhl G. Genetic perspectives on the serotonin transporter. Brain Res. Bull. 56 (2001) 487-494
55. Murphy D.L., Uhl G.R., Holmes A., Ren-Patterson R., Hall F.S., Sora I., Detera-Wadleigh S., and Lesch K.P. Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders. Genes Brain Behav. 2 (2003) 350-364
56. Murphy D.L., Lerner A., Rudnick G., and Lesch K.P. Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol. Interv. 4 (2004) 109-123
57. Nally R.E., McNamara F.N., Clifford J.J., Kinsella A., Tighe O., Croke D.T., Fienberg A.A., Greengard P., and Waddington J.L. Topographical assessment of ethological and dopamine receptor agonist-induced behavioral phenotype in mutants with congenic DARPP-32 'Knockout'. Neuropsychopharmacology 28 (2003) 2055-2063
58. 2-like dopamine receptor agonist- versus antagonist-induced behavioral topography in dopamine- and adenosine 3′,5′-monophosphate-regulated phosphoprotein of 32 kDa "knockout" mutants congenic on the C57BL/6 genetic background. J. Pharmacol. Exp. Ther. 310 (2004) 1281-1287
59. Nilsson M., Waters S., Waters N., Carlsson A., and Carlsson M.L. A behavioural pattern analysis of hypoglutamatergic mice-effects of four different antipsychotic agents. J. Neural Transm. 108 (2001) 1181-1196
60. Paulus M.P., and Geyer M.A. Three independent factors characterize spontaneous rat motor activity. Behav. Brain Res. 53 (1993) 11-20
61. Paulus M.P., Callaway C.W., and Geyer M.A. Quantitative assessment of the microstructure of rat behavior: II. Distinctive effects of dopamine releasers and uptake inhibitors. Psychopharmacology 113 (1993) 187-198
62. Paulus M.P., Geyer M.A., and Sternberg E. Differential movement patterns but not amount of activity in unconditioned motor behavior of Fischer, Lewis, and Sprague-Dawley rats. Physiol. Behav. 65 (1998) 601-606
63. Paulus M.P., Dulawa S.C., Ralph R.J., and Geyer M.A. Behavioral organization is independent of locomotor activity in 129 and C57 mouse strains. Brain Res. 835 (1999) 27-36
64. Payton A., Gibbons L., Davidson Y., Ollier W., Rabbitt P., Worthington J., Pickles A., Pendleton N., and Horan M. Influence of serotonin transporter gene polymorphisms on cognitive decline and cognitive abilities in a non-demented elderly population. Mol. Psychiatry 20 (2005) 1133-1139
65. Persico A.M., Mengual E., Moessner R., Hall F.S., Revay R.S., Sora I., Arellano J., DeFelipe J., Gimenez-Amaya J.M., Conciatori M., Marino R., Baldi A., Cabib S., Pascucci T., Uhl G.R., Murphy D.L., Lesch K.P., and Keller F. Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J. Neurosci. 21 (2001) 6862-6873
66. Powell S.B., Lehmann-Masten V.D., Paulus M.P., Gainetdinov R.R., Caron M.G., and Geyer M.A. MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice. Behav. Brain Res. 167 (2006) 365-372
67. Prinssen E.P., Ballard T.M., Kolb Y., and Nicolas L.B. The effects of serotonin reuptake inhibitors on locomotor activity in gerbils. Pharmacol. Biochem. Behav. 85 (2007) 44-49
68. 2 receptor antagonists. J. Neurosci. 21 (2001) 305-313
69. Reneman L., Schilt T., de Win M.M., Booij J., Schmand B., van den Brink W., and Bakker O. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. J. Psychopharmacol. 20 (2006) 389-399
70. Ren-Patterson R.F., Cochran L.W., Holmes A., Sherrill S., Huang S.J., Tolliver T., Lesch K.P., Lu B., and Murphy D.L. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J. Neurosci. Res. 79 (2005) 756-771
71. Roiser J.P., Rogers R.D., Cook L.J., and Sahakian B.J. The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls. Psychopharmacology 188 (2006) 213-227
72. Roiser J.P., Muller U., Clark L., and Sahakian B.J. The effects of acute tryptophan depletion and serotonin transporter polymorphism on emotional processing in memory and attention. Int. J. Neuropsychopharmacol. 10 (2007) 449-461
73. Salichon N., Gaspar P., Upton A.L., Picaud S., Hanoun N., Hamon M., De Maeyer E., Murphy D.L., Mossner R., Lesch K.P., Hen R., and Seif I. Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase A and 5-HT transporter knock-out mice. J. Neurosci. 21 (2001) 884-896
74. Steward C.A., and Reid I.C. Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity. Psychopharmacology 148 (2000) 2170-2223
75. Sutcliffe J.S., Delahanty R.J., Prasad H.C., McCauley J.L., Han Q., Jiang L., Li C., Folstein S.E., and Blakely R.D. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am. J. Hum. Genet. 77 (2005) 265-279
76. Torres G.E., Gainetdinov R.R., and Caron M.G. Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev., Neurosci. 4 (2003) 13-25
77. Uetake T. Can we really walk straight?. Am. J. Phys. Anthropol. 89 (1992) 19-27
78. Wong M.L., and Licinio J. From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat. Rev. Drug Discov. 3 (2004) 136-151
79. Xu Y., Sari Y., and Zhou F.C. Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development. Dev. Brain Res. 150 (2004) 151-161
80. Yonan A.L., Alarcon M., Cheng R., Magnusson P.K., Spence S.J., Palmer A.A., Grunn A., Juo S.H., Terwilliger J.D., Liu J., Cantor R.M., Geschwind D.H., and Gilliam T.C. A genome-wide screen of 345 families for autism-susceptibility loci. Am. J. Hum. Genet. 73 (2003) 886-897
81. Zhao S., Edwards J., Carroll J., Wiedholz L., Millstein R.A., Jaing C., Murphy D.L., Lanthorn T.H., and Holmes A. Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice. Neuroscience 140 (2006) 321-334